-
Entity
-
Individual
-
Location
-
C/O Hookipa Pharma Inc., 430 East 29 Th St., New York, New York
-
Summary
-
The estimated net worth of Michael Aaron Kelly is at least $1.94 M dollars as of June 14, 2024. Michael Aaron Kelly is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $895 K. Michael Aaron Kelly is the Director of AMICUS THERAPEUTICS, INC. and owns shares of AMICUS THERAPEUTICS, INC. (FOLD) stock worth about $521 K. Michael Aaron Kelly is the Director of DMC Global Inc. and owns shares of DMC Global Inc. (BOOM) stock worth about $448 K. Michael Aaron Kelly is the Director of HOOKIPA Pharma Inc. and owns shares of HOOKIPA Pharma Inc. (HOOK) stock worth about $60 K. Michael Aaron Kelly is the Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $17 K.